These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3771357)

  • 1. Bulk drugs and chemical substances.
    Gushee J
    J Am Vet Med Assoc; 1986 Oct; 189(8):878-9. PubMed ID: 3771357
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. United States Food and Drug Administration's viewpoint.
    Ley HL; Desmond FH
    Can Med Assoc J; 1968 Feb; 98(6):318-21. PubMed ID: 5636100
    [No Abstract]   [Full Text] [Related]  

  • 3. How good are our drugs?
    Miller LC
    Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276
    [No Abstract]   [Full Text] [Related]  

  • 4. Adulteration of drugs and foods: compendial approaches to lowering risk.
    Abernethy DR; Sheehan C; Griffiths JC; Williams RL;
    Clin Pharmacol Ther; 2009 Apr; 85(4):444-7. PubMed ID: 18463621
    [No Abstract]   [Full Text] [Related]  

  • 5. New classification of drugs.
    J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956
    [No Abstract]   [Full Text] [Related]  

  • 6. New drugs.
    Hussar DA
    Nursing; 1992 May; 22(5):55-61. PubMed ID: 1584496
    [No Abstract]   [Full Text] [Related]  

  • 7. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA approvals. New drugs, new uses.
    Rodman MJ
    RN; 1991 Mar; 54(3):61-8. PubMed ID: 2003204
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling the quality of Uncle Sam's drugs.
    Hecht A
    FDA Consum; 1977 May; 11(4):22-3. PubMed ID: 10316531
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on counterfeit drugs.
    FDA Consum; 2005; 39(5):6-7. PubMed ID: 16419283
    [No Abstract]   [Full Text] [Related]  

  • 11. F.D.A. to assess O.T.C. drugs for safety, efficacy, labeling.
    Bowles GC
    Mod Hosp; 1972 Mar; 118(3):126. PubMed ID: 5058060
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA pressure?
    Appleton BL
    Nature; 1990 Mar; 344(6262):99. PubMed ID: 2308647
    [No Abstract]   [Full Text] [Related]  

  • 13. Curbing counterfeit drugs.
    FDA Consum; 2006; 40(5):11. PubMed ID: 17326307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Control of drugs in foreign countries].
    Buriánek J; Parrák V
    Cesk Farm; 1973 Jul; 22(6):247-53. PubMed ID: 4732551
    [No Abstract]   [Full Text] [Related]  

  • 15. Assuring the quality of the nation's drugs. Interview by William E. Small.
    Michels D
    Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377
    [No Abstract]   [Full Text] [Related]  

  • 16. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?
    Moxley JH; Yingling GL; Edwards CC
    Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750
    [No Abstract]   [Full Text] [Related]  

  • 17. The integrity of generic drugs.
    Fisher DW
    Hosp Pract (Off Ed); 1989 Sep; 24(9):9. PubMed ID: 2504753
    [No Abstract]   [Full Text] [Related]  

  • 18. Biopharmaceutic equivalency and the role of the Food & Drug Administration.
    Hodges RM
    Am J Hosp Pharm; 1968 Mar; 25(3):121-7. PubMed ID: 5658859
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics standards versus standards for other drugs.
    Wright WW
    Am J Hosp Pharm; 1982 Jun; 39(6):1046-7. PubMed ID: 7102691
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigation of new drugs.
    Holsten DW; Weilerstein R
    Hospitals; 1972 Mar; 46(6):97-104. PubMed ID: 5009178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.